Page last updated: 2024-10-26

dipyridamole and Flaccid Quadriplegia

dipyridamole has been researched along with Flaccid Quadriplegia in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the prevalence of coronary artery disease (CAD) in patients with spinal cord injury (SCI), 47 clinically asymptomatic SCI patients received thallium-201 myocardial perfusion single photon emission computed tomography (Tl-201 SPECT) after dipyridamole administration for the diagnosis of CAD."3.73Evaluating the prevalence of silent coronary artery disease in asymptomatic patients with spinal cord injury. ( Ding, HJ; Lee, CS; Lee, ST; Lin, CC; Lu, YH, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, CS1
Lu, YH1
Lee, ST1
Lin, CC1
Ding, HJ1
Bauman, WA1
Raza, M1
Chayes, Z1
Machac, J1

Other Studies

2 other studies available for dipyridamole and Flaccid Quadriplegia

ArticleYear
Evaluating the prevalence of silent coronary artery disease in asymptomatic patients with spinal cord injury.
    International heart journal, 2006, Volume: 47, Issue:3

    Topics: Adult; Coronary Artery Disease; Dipyridamole; Electrocardiography; Female; Heart; Humans; Male; Midd

2006
Tomographic thallium-201 myocardial perfusion imaging after intravenous dipyridamole in asymptomatic subjects with quadriplegia.
    Archives of physical medicine and rehabilitation, 1993, Volume: 74, Issue:7

    Topics: Adult; Coronary Disease; Dipyridamole; Exercise; Heart; Hemodynamics; Humans; Infusions, Intravenous

1993